Biocon Biologics Ltd today announced that the U.S. Food and Drug Administration has approved Kirsty™ (Insulin Aspart-xjhz), ...

The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...

Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...

Nifty rose above 25,100 and Sensex gained 76 points, recovering from earlier losses led by sectoral strength.Stock-Specific ...

Market expert Neeraj Dewan advises caution on IT stocks due to unpromising results and unclear US business trends, suggesting ...

Premier Explosives shares rose 4 per cent after it landed export orders worth ₹105 crore for the supply of defence explosives ...

The Board of Directors of Oriental Hotels Limited, at its meeting held today have approved the financial results of the ...

The Board of Directors of Kretto Syscon Limited, at its meeting held today have approved the financial results of the company ...

The Board of Directors of ICICI Prudential Life Insurance Company Limited, at its meeting held today have approved the ...

The Board of Directors of Bank of Maharashtra Limited, at its meeting held today have approved the financial results of the ...

Biocon Biologics, a subsidiary of Biocon, has received approval from the US FDA for KIRSTY (Insulin Aspart-xjhz), 100 units/mL, marking it as the first and only interchangeable biosimilar to NovoLog ...